Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Category - AI/Machine learning
Invert launches Invert Assist, an AI-powered analysis interface built for bioprocess
ISAN FRANCISCO, CA, October 28, 2025 – Invert, a pioneer in AI-driven bioprocess software solutions, today announced the launch of Invert Assist, an AI-powered analysis interface for bioprocess that enables users to...read more
BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health
This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more
Why Are We Still Talking About Data Infrastructure for Life Sciences in 2025?
“In my twenty-five years in the Life Sciences industry, I’ve observed countless organizations adopt, revise, dismantle, and rebuild their data infrastructure.” While the rapid advancements of data technology certainly...read more
